AzTrials
AzTrials

DeconditioningS-PRESSNCT06175728

Feasbility and Efficacy of S-Press Leg Strengthening Device

A study testing S-Press in people with Deconditioning and Sarcopenia, run by Sheffield Hallam University at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed study will examine the use and effectiveness of a novel strength training device - The S-Press within an NHS environment. The S-Press is a portable exercise device that can be used seated or lying down and specifically targets the knee extensors and flexors. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Deconditioning, Sarcopenia
What is being tested?
S-Press
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
9 participants
Where
1 siteUnited Kingdom
Study dates
1 Apr 2021to 4 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Any in-patient admitted onto the ward sites for therapy intervention, assessed as medically stable and physically able to participate by nursing staff and able to provide informed written consent for participation.

Who cannot join

  • Any patient who is unable to give informed consent.
  • Significantly confused patients - may not understand or retain the information to perform the exercises so will be excluded from this study.
  • Patients with unstable or deteriorating medical conditions or are acutely unwell with an infection.
  • Patients unable to do leg press exercise
  • Patients who have had major surgery or myocardial infarction within the past 6 months.
  • Patients who have major surgery scheduled during the intervention period.
Show all 9Show fewer
  • Patients currently undergoing treatment for cancer
  • Patients who currently have high blood pressure that is uncontrolled (Systolic >200mmHg or Diastolic > 110mmHg)
  • Patients with a physical disability that precludes safe and adequate testing.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Northamptonshire NHS Trust

    Northampton, Northamptonshire

Other trials in United Kingdom

About this study

Official title: Feasibility, Usability, Acceptability and Efficacy of a Novel Leg Strengthening Device (S-Press) for Strengthening Leg Muscles and Improving Physical Impairment During Hospital Admission

The proposed study will examine the use and effectiveness of a novel strength training device - The S-Press within an NHS environment. The S-Press is a portable exercise device that can be used seated or lying down and specifically targets the knee extensors and flexors. The knee extensors are particularly important in the performance of activities of daily living such as rising from a chair, walking up and down stairs and walking.

Resistance training is the most effective strategy to help to reduce muscle wasting in response to ageing or chronic disuse; however as current in-patient settings likely fail to produce an overload stimulus to the muscle for hypertrophy and strength gains, there is a need to develop new interventions and equipment to help deliver this. The S-Press is designed by a Physiotherapist with the goal of increasing muscle strength and improving physical function in patients who may be confined to their bed or chair or unable to join in with standard physiotherapy treatments.

This mixed methods study will examine the efficacy of the S-Press to improve muscle size using B-Mode Ultrasound and physical function, using sit to stand x5 with use over 6 weeks, alongside the qualitative experience of the use of the S-Press through a one to one semi structured interview.

Being tested
S-Press
Medical subject headings
Sarcopenia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • S-PressDevice

    Leg Strengthening Device that can be used in supine and seated positions

Study groups in NCT06175728
Study groupRoleWhat they receive
Use of S-PressExperimentalUse of the S-Press during in patient stay alongside usual physiotherapy sessions
Receives: Device: S-Press

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasbility of use of S-Press by patients

    30 minute Semi Structured Interview

    Measured: through study completion, an average of 2 weeks

  2. Feasbility of use of S-Press by Healthcare Professionals

    30 minute Semi Structured Interview

    Measured: through study completion, an average of 2 weeks

Secondary outcomes (5)
  1. 5x Sit to Stand time

    time to complete 5 sit to stands from standardised chair

    Measured: through study completion, an average of 2 weeks

  2. Muscle thickness

    Ultrasound measurement of Vastus Lateralis

    Measured: through study completion, an average of 2 weeks

  3. Heart rate during use

    During exercise sessions

    Measured: through study completion, an average of 2 weeks

  4. Systolic Blood Pressure during use

    During exercise sessions

    Measured: through study completion, an average of 2 weeks

  5. Diastolic Blood Pressure during use

    During exercise sessions

    Measured: through study completion, an average of 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2023
  2. Study start1 Apr 2021
  3. Primary completion31 Jan 2023
  4. Study completion4 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
9 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06175728
Sponsor's protocol ID
SPRESS1
Acronym
S-PRESS
Status last verified
Dec 2023
First submitted
6 Sep 2023
Last updated
19 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual data are available on request

Questions about this trial

What is this clinical trial studying?

A study testing S-Press in people with Deconditioning and Sarcopenia, run by Sheffield Hallam University at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasbility of use of S-Press by patients (time frame: through study completion, an average of 2 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in